SBFM — Sunshine Biopharma Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1402328 ·
Last close
$0.82
Market Cap
$3.17M
52W High
$24.30
52W Low
$0.78
ADV30
515,088
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 9,263,687 | 2,426,682 | -1,612,858 | -1,564,048 | 33,632,901 | 13,748,301 | 6,094,899 |
| Mar 2026 | 8,088,765 | 2,180,990 | -1,395,597 | -1,243,869 | 27,930,375 | 6,913,013 | 6,413,781 |
| Dec 2025 | 8,577,141 | 3,028,845 | -1,658,223 | -2,140,927 | 30,079,167 | 9,123,308 | 7,040,707 |
| Sep 2025 | 9,417,179 | 3,073,540 | -531,963 | -883,820 | 31,487,379 | 9,306,438 | 7,288,023 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,708,171
Investing CF
$-728,807
Financing CF
$4,393,111
CapEx
$-728,807
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-12.70
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-76,258,995
Inventory
$13,168,430
Receivables
$4,011,632
ST Investments
—
EBIT TTM
$-6,129,408
Pretax Income TTM
$-5,977,680
Interest Exp TTM
$0
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$35,346,772
EBITDA
$-4,848,974
Free Cash Flow
$-2,011,131
Enterprise Value
$-9,228,466
Total Cash
$14,029,781
Total Debt
$678,338
Shares Out
3,877,337
Trailing EPS
$-9.16
Book Value
$11.52
ROE
-21.9%
ROA
-9.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,305,891 | -4,478,782 | -5,975,352 | 30,079,167 | 7,040,707 | 23,038,460 | -5,331,073 |
| Dec 2024 | 34,874,283 | -5,812,121 | -5,134,116 | 30,560,392 | 7,059,638 | 23,500,754 | -12,524,779 |
| Dec 2023 | 24,092,787 | -4,785,299 | -4,506,044 | 27,346,961 | 6,139,600 | 21,207,361 | -8,775,111 |
| Dec 2022 | 4,345,603 | -8,674,031 | -26,744,440 | 29,243,848 | 7,616,278 | 21,627,570 | -5,248,358 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$199.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | $3.17M | $0.05 | — |
| GOVX | GeoVax Labs, Inc. | $3.14M | $0.35 | — |
| XRTX | XORTX Therapeutics Inc. | $3.11M | $1.71 | — |
| RDHL | RedHill Biopharma Ltd. | $3.07M | $0.51 | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | $3.31M | $2.51 | — |
News headlines (Yahoo Finance, 1h cache)
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
2026-09-24 15:00 · Yahoo
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
2026-09-24 13:00 · Yahoo
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
2026-09-16 13:00 · Yahoo
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
2026-09-16 12:31 · Yahoo
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
2026-08-31 13:00 · Yahoo
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
2026-08-26 12:31 · Yahoo
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
2026-08-19 13:00 · Yahoo
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
2026-08-19 12:30 · Yahoo
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
2026-08-07 13:00 · Yahoo
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
2026-07-28 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.